Secondary recurrent miscarriage and H-Y immunity

Human Reproduction Update

Volumn 17, Issue 4, 2011, Pages 558-574

  Nielsen, Henriette Svarre ^a  

^a Rigshospitalet   (Denmark)

Author keywords

H Y antigen; Parity; Pregnancy complications; Pregnancy outcome; Secondary recurrent miscarriage

Indexed keywords

HLA ANTIBODY; HLA ANTIGEN CLASS 2; HY ANTIGEN;

ALLELE; ALLOGENEIC STEM CELL TRANSPLANTATION; ANTIGEN PRESENTATION; ARTICLE; BIRTH RATE; DONOR; EMBASE; FEMALE; FIRST TRIMESTER PREGNANCY; GENDER; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; LIVE BIRTH; MEDLINE; PREGNANCY COMPLICATION; PRIORITY JOURNAL; RECURRENT ABORTION; SEX RATIO;

ABORTION, HABITUAL; FEMALE; H-Y ANTIGEN; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; MALE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; RISK FACTORS;

EID: 79958694894     PISSN: 13554786     EISSN: 14602369     Source Type: Journal    
DOI: 10.1093/humupd/dmr005     Document Type: Article

References (122)

1. Adams KM, Nelson JL. Microchimerism: an investigative frontier in autoimmunity and transplantation. J Am Med Assoc 2004;291:1127-1131.
2. Adams KM, Yan Z, Stevens AM, Nelson JL. The changing maternal 'self' hypothesis: a mechanism for maternal tolerance of the fetus. Placenta 2007;28:378-382.
3. Ahrons S. HL-A antibodies: influence on the human foetus. Tissue Antigens 1971; 1:129-136.
4. Arruvito L, Sanz M, Banham AH, Fainboim L. Expansion of CD4+CD25+and FOXP3+ regulatory T cells during the follicular phase of the menstrual cycle: implications for human reproduction. J Immunol 2007;178:2572-2578.
5. Atkinson K, Farrell C, Chapman G, Downs K, Penny R, Biggs J. Female marrow donors increase the risk of acute graft-versus-host disease: effect of donor age and parity and analysis of cell subpopulations in the donor marrow inoculum. Br J Haematol 1986;63:231-239.
6. Atkinson K, Horowitz MM, Gale RP, van Bekkum DW, Gluckman E, Good RA, Jacobsen N, Kolb HJ, Rimm AA, Ringden O et al. Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood 1990;75:2459-2464.
7. Bagshi D, Fridman T. Psychological aspects of spontaneous and recurrent abortion. Curr Obstet Gynaecol 1999;9:19-22.
8. Balasch J, Ercilla G, Vanrell JA, Vives J, Gonzalez-Merlo J. Effects of HLA antibodies on pregnancy. Obstet Gynecol 1981;57:444-446.
9. Beard RW, Braude P, Mowbray JF, Underwood JL. Protective antibodies and spontaneous abortion. Lancet 1983;2:1090.
10. Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci USA 1996;93:705-708.
11. Bianchi DW, Farina A, Weber W, Li-Bovi LC, Deriso M, Williams JM, Klinger KW. Significant fetal-maternal hemorrhage after termination of pregnancy: implications for development of fetal cell microchimerism. Am J Obstet Gynecol 2001;184:703-706.
12. Boue J, Bou A, Lazar P. Retrospective and prospective epidemiological studies of 1500 karyotyped spontaneous human abortions. Teratology 1975;12:11-26.
13. Bross DS, Tutschka PJ, Farmer ER, Beschorner WE, Braine HG, Mellits ED, Bias WB, Santos GW. Predictive factors for acute graft-versus-host disease in patients transplanted with HLA-identical bone marrow. Blood 1984;63:1265-1270.
14. Byrne J, Warburton D. Male excess among anatomically normal fetuses in spontaneous abortions. Am J Med Genet 1987;26:605-611.
15. Carlens S, Ringden O, Remberger M, Lonnqvist B, Hagglund H, Klaesson S, Mattsson J, Svahn BM, Winiarski J, Ljungman P et al. Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis. Bone Marrow Transplant 1998;22:755-761.
16. Chambers CA, Kuhns MS, Egen JG, Allison JP. CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy. Annu Rev Immunol 2001;19:565-594.
17. Christiansen OB, Mathiesen O, Lauritsen JG, Grunnet N. Study of the birthweight of parents experiencing unexplained recurrent miscarriages. Br J Obstet Gynaecol 1992;99:408-411.
18. Christiansen OB, Pedersen B, Rosgaard A, Husth M. A randomized, double-blind, placebo-controlled trial of intravenous immunoglobulin in the prevention of recurrent miscarriage: evidence for a therapeutic effect in women with secondary recurrent miscarriage. Hum Reprod 2002;17:809-816.
19. Christiansen OB, Pedersen B, Nielsen HS, Nybo Andersen AM. Impact of the sex of first child on the prognosis in secondary recurrent miscarriage. Hum Reprod 2004; 19:2946-2951.
20. Christiansen OB, Nybo Andersen AM, Bosch E, Daya S, Delves PJ, Hviid TV, Kutteh WH, Laird SM, Li TC, van d V. Evidence-based investigations and treatments of recurrent pregnancy loss. Fertil Steril 2005;83:821-839.
21. Christiansen OB, Kolte AM, Nielsen HS. Secondary recurrent miscarriage-a unique entity with respect to etiology and treatment. Curr Women's Health Rev 2006; 2:119-123.
22. Christiansen OB, Steffensen R, Nielsen HS, Varming K. Multifactorial etiology of recurrent miscarriage and its scientific and clinical implications. Gynecol Obstet Invest 2008;66:257-267.
23. Coulam CB. Immunologic tests in the evaluation of reproductive disorders: a critical review. Am J Obstet Gynecol 1992;167:1844-1851.
24. Coulam CB, Stephenson M, Stern JJ, Clark DA. Immunotherapy for recurrent pregnancy loss: analysis of results from clinical trials. Am J Reprod Immunol 1996; 35:352-359.
25. Eichwald EJ, Silmser CR. Skin. Transplant Bull 1955;2:148-149.
26. Evans PC, Lambert N, Maloney S, Furst DE, Moore JM, Nelson JL. Long-term fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and women with scleroderma. Blood 1999;93:2033-2037.
27. Faber LM, van Luxemburg-Heijs SA, Veenhof WF, Willemze R, Falkenburg JH. Generation of CD4+ cytotoxic T-lymphocyte clones from a patient with severe graft-versus-host disease after allogeneic bone marrow transplantation: implications for graft-versus-leukemia reactivity. Blood 1995;86:2821-2828.
28. Flowers ME, Pepe MS, Longton G, Doney KC, Monroe D, Witherspoon RP, Sullivan KM, Storb R. Previous donor pregnancy as a risk factor for acute graft-versus-host disease in patients with aplastic anaemia treated by allogeneic marrow transplantation. Br J Haematol 1990;74:492-496.
29. Gale RP, Bortin MM, van Bekkum DW, Biggs JC, Dicke KA, Gluckman E, Good RA, Hoffmann RG, Kay HE, Kersey JH et al. Risk factors for acute graft-versus-host disease. Br J Haematol 1987;67:397-406.
30. Gerber S, Vardhana S, Meagher-Villemure K, Vial Y, Hohlfeld P, Witkin SS. Association between fetal interleukin-1 receptor antagonist gene polymorphism and unexplained fetal death. Am J Obstet Gynecol 2005; 193:1472-1477.
31. Germain SJ, Sacks GP, Sooranna SR, Sargent IL, Redman CW. Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles. J Immunol 2007;178:5949-5956.
32. Girardi G, Yarilin D, Thurman JM, Holers VM, Salmon JE. Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction. J Exp Med 2006;203:2165-2175.
33. Goulmy E, Termijtelen A, Bradley BA, van Rood JJ. Alloimmunity to human H-Y. Lancet 1976;2:1206.
34. Gratwohl A, Hermans J, Goldman JM, ArceseW, Carreras E, Devergie A, Frassoni F, Gahrton G, Kolb HJ, Niederwieser D et al. Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Lancet 1998;352:1087-1092.
35. Gratwohl A, Hermans J, Niederwieser D, van BA, van Houwelingen HC, Apperley J. Female donors influence transplant-related mortality and relapse incidence in male recipients of sibling blood and marrow transplants. Hematol J 2001; 2:363-370.
36. Halder A, Fauzdar A. Skewed sex ratio and low aneuploidy in recurrent early missed abortion. Indian J Med Res 2006;124:41-50.
37. Hambach L, Spierings E, Goulmy E. Risk assessment in haematopoietic stem cell transplantation: minor histocompatibility antigens. Best Pract Res Clin Haematol 2007;20:171-187.
38. Hansen D, Moller H, Olsen J. Severe periconceptional life events and the sex ratio in offspring: follow up study based on five national registers. Br Med J 1999; 319:548-549.
39. Huppertz B, Kaufmann P, Kingdom J. Trophoblast turnover in health and disease. Fetal Maternal Med Rev 2002;13:103-118.
40. Hutton B, Sharma R, Fergusson D, Tinmouth A, Hebert P, Jamieson J, Walker M. Use of intravenous immunoglobulin for treatment of recurrent miscarriage: a systematic review. BJOG 2007;114:134-142.
41. Hviid TV, Christiansen OB. Linkage disequilibrium between human leukocyte antigen (HLA) class II and HLA-G-possible implications for human reproduction and autoimmune disease. Hum Immunol 2005;66:688-699.
42. Jacobs PA, Hassold TJ, Henry A, Pettay D, Takaesu N. Trisomy 13 ascertained in a survey of spontaneous abortions. J Med Genet 1987;24:721-724.
43. James E, Chai JG, Dewchand H, Macchiarulo E, Dazzi F, Simpson E. Multiparity induces priming to male-specific minor histocompatibility antigen, HY, in mice and humans. Blood 2003;102:388-393.
44. Jiang SP, Vacchio MS. Multiple mechanisms of peripheral T cell tolerance to the fetal 'allograft'. J Immunol 1998;160:3086-3090.
45. Jivraj S, Anstie B, Cheong YC, Fairlie FM, Laird SM, Li TC. Obstetric and neonatal outcome in women with a history of recurrent miscarriage: a cohort study. Hum Reprod 2001;16:102-106.
46. Johnson PM, Barnes RM, Hart CA, Francis WJ. Determinants of immunological responsiveness in recurrent spontaneous abortion. Transplantation 1984; 38:280-284.
47. Kahn DA, Baltimore D. Pregnancy induces a fetal antigen-specific maternal T regulatory cell response that contributes to tolerance. Proc Natl Acad Sci USA 2010;107:9299-9304.
48. Kano T, Mori T, Kimura A. Gender ratio distortion in abortuses and live births from patients with recurrent spontaneous abortion. Am J Reprod Immunol 2009; 62:125-127.
49. Katz VL, Kuller JA. Recurrent miscarriage. Am J Perinatol 1994;11:386-397.
50. Khashan AS, Mortensen PB, McNamee R, Baker PN, Abel KM. Sex ratio at birth following prenatal maternal exposure to severe life events: a population-based cohort study. Hum Reprod 2009.
51. Khosrotehrani K, Johnson KL, Lau J, Dupuy A, Cha DH, Bianchi DW. The influence of fetal loss on the presence of fetal cell microchimerism: a systematic review. Arthritis Rheum 2003;48:3237-3241.
52. Kollman C, Howe CW, Anasetti C, Antin JH, Davies SM, Filipovich AH, Hegland J, Kamani N, Kernan NA, King R et al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood 2001;98:2043-2051.
53. Kolte AM, Steffensen R, Nielsen HS, Hviid TV, Christiansen OB. Study of the structure and impact of human leukocyte antigen (HLA)-G-A, HLA-G-B, and HLA-G-DRB1 haplotypes in families with recurrent miscarriage. Hum Immunol 2010;71:482-488.
54. Krco CJ, Goldberg EH. H-Y male antigen: detection on eight-cell mouse embryos. Science 1976;193:1134-1135.
55. Kruse C, Steffensen R, Varming K, Christiansen OB. A study of HLA-DR and -DQ alleles in 588 patients and 562 controls confirms that HLA-DRB1*03 is associated with recurrent miscarriage. Hum Reprod 2004;19:1215-1221.
56. Lahn BT, Page DC. Functional coherence of the human Y chromosome. Science 1997;278:675-680.
57. Lehmann PV, Sercarz EE, Forsthuber T, Dayan CM, Gammon G. Determinant spreading and the dynamics of the autoimmune T-cell repertoire. Immunol Today 1993;14:203-208.
58. Leung TN, Zhang J, Lau TK, Chan LY, Lo YM. Increased maternal plasma fetal DNA concentrations in women who eventually develop preeclampsia. Clin Chem 2001; 47:137-139.
59. Lo YM, Leung TN, Tein MS, Sargent IL, Zhang J, Lau TK, Haines CJ, Redman CW. Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin Chem 1999;45:184-188.
60. Loren AW, Bunin GR, Boudreau C, Champlin RE, Cnaan A, Horowitz MM, Loberiza FR, Porter DL. Impact of donor and recipient sex and parity on outcomes of HLA-identical sibling allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2006;12:758-769.
61. Lummaa V, Pettay JE, Russell AF. Male twins reduce fitness of female co-twins in humans. Proc Natl Acad Sci USA 2007;104:10915-10920.
62. Lund M, Nielsen HS, Hviid TV, Steffensen R, Nyboe AA, Christiansen OB. Hereditary thrombophilia and recurrent pregnancy loss: a retrospective cohort study of pregnancy outcome and obstetric complications. Hum Reprod 2010.
63. Magnus P, Berg K, Bjerkedal T. The association of parity and birth weight: testing the sensitization hypothesis. Early Hum Dev 1985;12:49-54.
64. McIntyre JA, McConnachie PR, Taylor CG, Faulk WP. Clinical, immunologic, and genetic definitions of primary and secondary recurrent spontaneous abortions. Fertil Steril 1984;42:849-855.
65. Miklos DB, Kim HT, Zorn E, Hochberg EP, Guo L, Mattes-Ritz A, Viatte S, Soiffer RJ, Antin JH, Ritz J. Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors. Blood 2004;103:353-359.
66. Miklos DB, Kim HT, Miller KH, Guo L, Zorn E, Lee SJ, Hochberg EP, Wu CJ, Alyea EP, Cutler C et al. Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission. Blood 2005;105:2973-2978.
67. Moldenhauer LM, Diener KR, Thring DM, Brown MP, Hayball JD, Robertson SA. Cross-presentation of male seminal fluid antigens elicits T cell activation to initiate the female immune response to pregnancy. J Immunol 2009; 182:8080-8093.
68. Morales C, Sanchez A, Bruguera J, Margarit E, Borrell A, Borobio V, Soler A. Cytogenetic study of spontaneous abortions using semi-direct analysis of chorionic villi samples detects the broadest spectrum of chromosome abnormalities. Am J Med Genet A 2008;146A:66-70.
69. Mortensen LH, Nielsen HS, Cnattingius S, Andersen AM. Sex of the First-born and risk of preterm birth in the subsequent pregnancy. Epidemiology 2011; Jan. 28 [Epub ahead of print].
70. Mutis T, Gillespie G, Schrama E, Falkenburg JH, Moss P, Goulmy E. Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease. Nat Med 1999;5:839-842.
71. Nash RA, Pepe MS, Storb R, Longton G, Pettinger M, Anasetti C, Appelbaum FR, Bowden RA, Deeg HJ, Doney K et al. Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate. Blood 1992;80:1838-1845.
72. Nielsen HS, Mogensen M, Steffensen R, Kruse C, Christiansen OB. Indications of anti-HY immunity in recurrent placental abruption. J Reprod Immunol 2007; 75:63-69.
73. Nielsen HS, Andersen AM, Kolte AM, Christiansen OB. A firstborn boy is suggestive of a strong prognostic factor in secondary recurrent miscarriage: a confirmatory study. Fertil Steril 2008a;89:907-911.
74. Nielsen HS, Mortensen L, Nygaard U, Schnor O, Christiansen OB, Andersen AM. Brothers and reduction of the birth weight of later-born siblings. Am J Epidemiol 2008b;167:480-484.
75. Nielsen HS, Steffensen R, Varming K, van Halteren AG, Spierings E, Ryder LP, Goulmy E, Christiansen OB. Association of HY-restricting HLA class II alleles with pregnancy outcome in patients with recurrent miscarriage subsequent to a firstborn boy. Hum Mol Genet 2009;18:1684-1691.
76. Nielsen HS, Mortensen LH, Nygaard U, Schnor O, Christiansen OB, Andersen AM. Sex of prior children and risk of stillbirth in subsequent pregnancies. Epidemiology 2010a;21:114-117.
77. Nielsen HS, Steffensen R, Lund M, Egestad L, Mortensen LH, Andersen AM, Lidegaard O, Christiansen OB. Frequency and impact of obstetric complications prior and subsequent to unexplained secondary recurrent miscarriage. Hum Reprod 2010b;25:1543-1552.
78. Nielsen HS, Witvliet MD, Steffensen R, Haasnoot GW, Goulmy E, Christiansen OB, Claas F. The presence of HLA-antibodies in recurrent miscarriage patients is associated with a reduced chance of a live birth. J Reprod Immunol 2010c.
79. Nielsen HS, Wu F, Aghai Z, Steffensen R, van Halteren AG, Spierings E, Christiansen OB, Miklos D, Goulmy E. H-Y antibody titers are increased in unexplained secondary recurrent miscarriage patients and associated with low male: female ratio in subsequent live births. Hum Reprod 2010d; 25:2745-2752.
80. Ogasawara M, Aoki K, Okada S, Suzumori K. Embryonic karyotype of abortuses in relation to the number of previous miscarriages. Fertil Steril 2000;73:300-304.
81. Ohno M, Maeda T, Matsunobu A. A cytogenetic study of spontaneous abortions with direct analysis of chorionic villi. Obstet Gynecol 1991;77:394-398.
82. Ott PA, Dittrich MT, Herzog BA, Guerkov R, Gottlieb PA, Putnam AL, Durinovic-Bello I, Boehm BO, Tary-Lehmann M, Lehmann PV. T cells recognize multiple GAD65 and proinsulin epitopes in human type 1 diabetes, suggesting determinant spreading. J Clin Immunol 2004;24:327-339.
83. Piper KP, McLarnon A, Arrazi J, Horlock C, Ainsworth J, Kilby MD, Martin WL, Moss PA. Functional HY-specific CD8+ T cells are found in a high proportion of women following pregnancy with a male fetus. Biol Reprod 2007;76:96-101.
84. Power DA, Catto GR, Mason RJ, MacLeod AM, Stewart GM, Stewart KN, Shewan WG. The fetus as an allograft: evidence for protective antibodies to HLA-linked paternal antigens. Lancet 1983;2:701-704.
85. Przepiorka D, Smith TL, Folloder J, Khouri I, Ueno NT, Mehra R, Korbling M, Huh YO, Giralt S, Gajewski J et al. Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation. Blood 1999; 94:1465-1470.
86. Quenby SM, Farquharson RG. Predicting recurring miscarriage: what is important? Obstet Gynecol 1993;82:132-138.
87. Raghupathy R. Th1-type immunity is incompatible with successful pregnancy. Immunol Today 1997;18:478-482.
88. Ramalho MF, Garcia JM, Esper CR, Vantini R, Alves BC, Meida Junior IL, Hossepian de Lima VF, Moreira-Filho CA. Sexing of murine and bovine embryos by developmental arrest induced by high-titer H-Y antisera. Theriogenology 2004; 62:1569-1576.
89. Randolph SS, Gooley TA, Warren EH, Appelbaum FR, Riddell SR. Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants. Blood 2004; 103:347-352.
90. Regan L, Braude PR, Hill DP. A prospective study of the incidence, time of appearance and significance of anti-paternal lymphocytotoxic antibodies in human pregnancy. Hum Reprod 1991;6:294-298.
91. Remberger M, Kumlien G, Aschan J, Barkholt L, Hentschke P, Ljungman P, Mattsson J, Svennilson J, Ringden O. Risk factors for moderate-to-severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2002;8:674-682.
92. Rickard IJ, Russell AF, Lummaa V. Producing sons reduces lifetime reproductive success of subsequent offspring in pre-industrial Finns. Proc Biol Sci 2007; 274:2981-2988.
93. Sargent IL, Wilkins T, Redman CW. Maternal immune responses to the fetus in early pregnancy and recurrent miscarriage. Lancet 1988;2:1099-1104.
94. Singal DP, Wadia YJ, Naipaul N. In vitro cell-mediated cytotoxicity to the male specific (H-Y) antigen in man. Hum Immunol 1981;2:45-53.
95. Spierings E, Vermeulen CJ, Vogt MH, Doerner LE, Falkenburg JH, Mutis T, Goulmy E. Identification of HLA class II-restricted H-Y-specific T-helper epitope evoking CD4+ T-helper cells in H-Y-mismatched transplantation. Lancet 2003; 362:610-615.
96. Steinborn A, Seidl C, Sayehli C, Sohn C, Seifried E, Kaufmann M, Schmitt E. Anti-fetal immune response mechanisms may be involved in the pathogenesis of placental abruption. Clin Immunol 2004;110:45-54.
97. Steinborn A, Saran G, Schneider A, Fersis N, Sohn C, Schmitt E. The presence of gestational diabetes is associated with increased detection of anti-HLA-class II antibodies in the maternal circulation. Am J Reprod Immunol 2006;56: 124-134.
98. Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol 2003;21:685-711.
99. Stephenson M, Bossano C, Schultz P. Accurate chromosome testing of miscarriages requires conventional cytogenetic analysis and selective DNA technologies. Hum Reprod 2009;24 (suppl 1):i8, o-018.
100. Stephenson MD. Frequency of factors associated with habitual abortion in 197 couples. Fertil Steril 1996;66:24-29.
101. Stephenson MD, Awartani KA, Robinson WP. Cytogenetic analysis of miscarriages from couples with recurrent miscarriage: a case-control study. Hum Reprod 2002;17:446-451.
102. Stephenson MD, Kutteh WH, Purkiss S, Librach C, Schultz P, Houlihan E, Liao C. Intravenous immunoglobulin and idiopathic secondary recurrent miscarriage: a multicentered randomized placebo-controlled trial. Hum Reprod 2010; 25:2203-2209.
103. Storb R, Prentice RL, Thomas ED. Treatment of aplastic anemia by marrow transplantation from HLA identical siblings. Prognostic factors associated with graft versus host disease and survival. J Clin Invest 1977;59:625-632.
104. Tafuri A, Alferink J, Moller P, Hammerling GJ, Arnold B. T cell awareness of paternal alloantigens during pregnancy. Science 1995;270:630-633.
105. Takakuwa K, Adachi H, Hataya I, Ishii K, Tamura M, Tanaka K. Molecular genetic studies of HLA-DRB1 alleles in patients with unexplained recurrent abortion in the Japanese population. Hum Reprod 2003;18:728-733.
106. Tekolf WA, Shaw S. In vitro generation of cytotoxic cells specific for human minor histocompatibility antigens by lymphocytes from a normal donor potentially primed during pregnancy. J Exp Med 1983;157:2172-2177.
107. Tulppala M, Palosuo T, Ramsay T, Miettinen A, Salonen R, Ylikorkala O. A prospective study of 63 couples with a history of recurrent spontaneous abortion: contributing factors and outcome of subsequent pregnancies. Hum Reprod 1993;8:764-770.
108. Utsumi K, Hayashi M, Takakura R, Utaka K, Iritani A. Embryo sex selection by a rat male-specific antibody and the cytogenetic and developmental confirmation in cattle embryos. Mol Reprod Dev 1993;34:25-32.
109. van Els CA, Bakker A, Zwinderman AH, Zwaan FE, van Rood JJ, Goulmy E. Effector mechanisms in graft-versus-host disease in response to minor histocompatibility antigens. II. Evidence of a possible involvement of proliferative T cells. Transplantation 1990a;50:67-71.
110. van Els CA, Zantvoort E, Jacobs N, Bakker A, van Rood JJ, Goulmy E. Graft-versus-host disease associated T helper cell responses specific for minor histocompatibility antigens are mainly restricted by HLA-DR molecules. Bone Marrow Transplant 1990b;5:365-372.
111. van Els CA, D'Amaro J, Pool J, Blokland E, Bakker A, van Elsen PJ, van Rood JJ, Goulmy E. Immunogenetics of human minor histocompatibility antigens: their polymorphism and immunodominance. Immunogenetics 1992;35: 161-165.
112. van Halteren AG, Jankowska-Gan E, Joosten A, Blokland E, Pool J, Brand A, Burlingham WJ, Goulmy E. Naturally acquired tolerance and sensitization to minor histocompatibility antigens in healthy family members. Blood 2009; 114:2263-2272.
113. Verdijk RM, Kloosterman A, Pool J, van de KM, Naipal AM, van Halteren AG, Brand A, Mutis T, Goulmy E. Pregnancy induces minor histocompatibility antigen-specific cytotoxic T cells: implications for stem cell transplantation and immunotherapy. Blood 2004;103:1961-1964.
114. Warburton D, Kline J, Stein Z, Hutzler M, Chin A, Hassold T. Does the karyotype of a spontaneous abortion predict the karyotype of a subsequent abortion? Evidence from 273 women with two karyotyped spontaneous abortions. Am J Hum Genet 1987;41:465-483.
115. Warren EH, Gavin MA, Simpson E, Chandler P, Page DC, Disteche C, Stankey KA, Greenberg PD, Riddell SR. The human UTY gene encodes a novel HLA-B8-restricted H-Y antigen. J Immunol 2000;164:2807-2814.
116. Weintraub AY, Sheiner E, Bashiri A, Shoham-Vardi I, Mazor M. Is there a higher prevalence of pregnancy complications in a live-birth preceding the appearance of recurrent abortions? Arch Gynecol Obstet 2005;271: 350-354.
117. Yang CJ, Stone P, Stewart AW. The epidemiology of recurrent miscarriage: a descriptive study of 1214 prepregnant women with recurrent miscarriage. Aust N Z J Obstet Gynaecol 2006;46:316-322.
118. Zelenika D, Adams E, Mellor A, Simpson E, Chandler P, Stockinger B, Waldmann H, Cobbold SP. Rejection of H-Y disparate skin grafts by monospecific CD4+ Th1 and Th2 cells: no requirement for CD8+ T cells or B cells. J Immunol 1998; 161:1868-1874.
119. Zhang LI, Martin DR, Fung-Leung WP, Teh HS, Miller RG. Peripheral deletion of mature CD8+ antigen-specific T cells after in vivo exposure to male antigen. J Immunol 1992;148:3740-3745.
120. Zhong XY, Holzgreve W, Hahn S. Circulatory fetal and maternal DNA in pregnancies at risk and those affected by preeclampsia. Ann N Y Acad Sci 2001; 945:138-140.
121. Zhu WX, Lu L, Hesketh T. China's excess males, sex selective abortion, and one child policy: analysis of data from 2005 national intercensus survey. Br Med J 2009;338:b1211.
122. Zorn E, Miklos DB, Floyd BH, Mattes-Ritz A, Guo L, Soiffer RJ, Antin JH, Ritz J. Minor histocompatibility antigen DBY elicits a coordinated B and T cell response after allogeneic stem cell transplantation. J Exp Med 2004; 199:1133-1142.